Profiling the immune landscape in mucinous ovarian carcinoma

CONCLUSION: In summary, MOCs are mostly immunogenically 'cold', suggesting they may have limited response to current immunotherapies.PMID:36368129 | DOI:10.1016/j.ygyno.2022.10.022

Source: Ann Oncol - November 11, 2022 Category: Cancer & Oncology Authors: Nicola S Meagher Phineas Hamilton Katy Milne Shelby Thornton Bronwyn Harris Ashley Weir Jennifer Alsop Christiani Bisinoto James D Brenton Angela Brooks-Wilson Derek S Chiu Kara L Cushing-Haugen Sian Fereday Dale W Garsed Simon A Gayther Aleksandra Gentry Source Type: research